Foresight Acquisition Corp.
Completed 2021-12-03- CIK 1832511
- FORE
- Now PIII
- IPO 2021-02-11
- $316M trust
- 400 filings
Successfully merged with P3 Health Group Holdings, LLC • Now trading as PIII
- IPO Size
- $316M
- raised at the IPO
- Trust
- $316M
- as of 2021-09-30
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
400 filings over 24 quarters; violet bars carry a milestone
- 20 Q4: 2 filings
- 21 Q1: 29 filings
- 21 Q2: 12 filings
- 21 Q3: 6 filings
- 21 Q4: 57 filings
- 22 Q1: 24 filings
- 22 Q2: 9 filings
- 22 Q3: 6 filings
- 22 Q4: 31 filings
- 23 Q1: 16 filings
- 23 Q2: 39 filings
- 23 Q3: 16 filings
- 23 Q4: 24 filings
- 24 Q1: 21 filings
- 24 Q2: 27 filings
- 24 Q3: 10 filings
- 24 Q4: 6 filings
- 25 Q1: 8 filings
- 25 Q2: 12 filings
- 25 Q3: 11 filings
- 25 Q4: 4 filings
- 26 Q1: 11 filings
- 26 Q2: 12 filings
- 26 Q3: 7 filings
- S-1 filed 20 Q4
- IPO 21 Q1
- Definitive agreement 21 Q2
- Completed 21 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Foresight Acquisition Corp. is a blank-check company seeking a business combination, initially focused on technology-enabled consumer and consumer healthcare businesses.
Investment Focus
Consumer, Healthcare
Key Information
As the filings state it
- IPO Date
- 2021-02-11
- Total Redemptions
- $279M
- PIPE
- $204M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2021-12-03
- Merger Target
- P3 Health Group Holdings, LLC
- SPAC Ticker
- FORE
- Merged Ticker
- PIII
Stock Performance
PIIITrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2021-04-06 | $10.00 | |
| At Merger | 2021-12-06 | $10.76 | +8% |
| 6 Months Post-Merger | 2022-06-06 | $4.94 | -54% |
| 1 Year Post-Merger | 2022-12-07 | $4.21 | -61% |
| 2 Years Post-Merger | 2023-12-06 | $1.15 | -89% |
| Current Price | 2026-10-02 | $6.36 | -36% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by former Walgreens Boots Alliance CEO Greg Wasson, small-cap investment managers Michael Balkin and Karl Brewer, and CFO Gerald Muizelaar, the team combines public-company operations, consumer and healthcare experience, private-equity leadership, and investment expertise.